Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 1 Interventional

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

ClinicalTrials.gov ID: NCT06001788

Public ClinicalTrials.gov record NCT06001788. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 18, 2026, 4:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia

Study identification

NCT ID
NCT06001788
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Kura Oncology, Inc.
Industry
Enrollment
171 participants

Conditions and interventions

Interventions

  • Cytarabine Drug
  • Fludarabine Drug
  • Gilteritinib Drug
  • Granulocyte colony-stimulating factor Biological
  • Idarubicin Drug
  • Ziftomenib Drug

Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 21, 2024
Primary completion
Jul 31, 2026
Completion
Jul 31, 2027
Last update posted
Apr 13, 2026

2024 – 2027

United States locations

U.S. sites
38
U.S. states
25
U.S. cities
35
Facility City State ZIP Site status
Banner MD Anderson Cancer Center Gilbert Arizona 85234 Recruiting
USC Norris Comprehensive Cancer Center Los Angeles California 90089 Recruiting
UCLA Health - Bowyer Oncology Center Los Angeles California 90095 Recruiting
UC Irvine Health Chao Family Comprehensive Cancer Center Orange California 92868 Recruiting
University of California San Francisco San Francisco California 94115 Recruiting
Colorado Blood Cancer Institute Denver Colorado 80218 Recruiting
Smilow Cancer Hospital at Yale New Haven New Haven Connecticut 06511 Recruiting
Emory Healthcare - The Emory Clinic Atlanta Georgia 30322 Recruiting
Georgia Cancer Center at Augusta University Augusta Georgia 30912 Recruiting
Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago Illinois 60611 Recruiting
Loyola University Medical Center Maywood Illinois 60153 Recruiting
Simmons Cancer Institute Springfield Illinois 62702 Withdrawn
University of Iowa Hospitals & Clinics Iowa City Iowa 52242 Recruiting
The University of Kansas Cancer Center Kansas City Kansas 66160 Recruiting
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 Recruiting
Karmanos Cancer Institute Detroit Michigan 48201 Recruiting
Henry Ford Cancer Institute Detroit Michigan 48202 Recruiting
Washington University School of Medicine St Louis Missouri 63110 Recruiting
University of Nebraska Medical Center Omaha Nebraska 68198 Recruiting
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 Recruiting
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 Recruiting
Northwell Health, LLC PRIME Lake Success New York 11042 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10021 Recruiting
Weill Cornell Medical College-NY Presbyterian Hospital New York New York 10065 Recruiting
Wilmot Cancer Institute, University of Rochester Rochester New York 14642 Recruiting
Stony Brook Cancer Center Stony Brook New York 11794 Recruiting
Atrium Health Levine Cancer Center Charlotte North Carolina 60201 Recruiting
UH Seidman Cancer Center Cleveland Ohio 44106 Recruiting
OU Health Stephenson Cancer Center Oklahoma City Oklahoma 73104 Recruiting
Lehigh Valley Topper Cancer Institute Allentown Pennsylvania 18103 Withdrawn
Prisma Health Greenville South Carolina 29615 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37232 Recruiting
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 Recruiting
MD Anderson Cancer Center Houston Texas 77030 Recruiting
University of Vermont Burlington Vermont 05401 Recruiting
University of Virginia Comprehensive Cancer Center Charlottesville Virginia 22903 Recruiting
University of Washington Seattle Washington 98109 Recruiting
Froedtert & Medical College Clinics Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06001788, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06001788 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →